Related Experiment Video
Updated: Sep 4, 2026

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
Hepatic steatosis risk in nonobese Chinese adults with type 1 diabetes
Zehua Jin1, Jianhua Ma1, Yuanyang Zhao2
1Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Abstract:
Metabolic dysfunction-associated steatotic liver disease (MASLD) may be an important comorbidity in nonobese Chinese adults with type 1 diabetes (T1D). We assessed the likelihood of hepatic steatosis using the hepatic steatosis index (HSI) in 47 nonobese Chinese adults with T1D (mean age 46.9 ± 14.1 years; BMI 22.6 ± 2.5 kg/m2) and examined its association with insulin requirements. Overall, 27.7% of participants had an HSI >36, indicating a high likelihood of MASLD. Compared with those with HSI <30 (low likelihood of MASLD), individuals with HSI >36 required higher bolus and total daily insulin doses, while achieving comparable glycemic profiles. These findings demonstrate that an HSI >36 is relatively common in nonobese Chinese adults with T1D and is associated with higher insulin requirements. MASLD may therefore represent an under-recognized but clinically relevant comorbidity in nonobese Chinese adults with T1D, warranting greater attention in screening and management strategies.
Related Concept Videos
Type II Diabetes I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes: Symptoms, Diagnosis, and Complications
Type II Diabetes II: Pathophysiology
Type I Diabetes I: Introduction
